Barbara Eichhorst

University Hospital Cologne, Germany

Barbara Eichhorst graduated at the Medical school of the University of Munich in 1997. She did her doctoral thesis in the field of hematology evaluating signalling transduction pathways in Hodgkin cells. Dr Eichhorst finished her internship at the department III for internal medicine at Klinikum Großhadern of the University of Munich and specialized in internal medicine. Since February 2005 she works at the Department I for Internal Medicine at the University hospital of Cologne, one of the largest clinics for hematology and oncology in Germany, and finished her specialisation in hematology and internal oncology. She is assistant professor and consultant since December 2012 and adjunct professor of the University of Cologne since July 2019.

Her main focus of interest is chronic lymphocytic leukemia (CLL). As leading group member of the German CLL Study Group (GCLLSG) she was and is principal investigator in several phase II and III trials evaluating treatment optimization in CLL. Since 2005 she is secretary of the GCLLSG (head Prof. Dr. Michael Hallek). Publishing many papers in the field of CLL treatment within clinical trials Barbara Eichhorst is a world-wide known specialist for CLL. She is also a member of many national and international organizations including the European Haematology association and American Society of Hematology.

Broadcast Time Zone is Central European Time (CET)
Approximately one week before the Congress, all registered delegates will receive an invitation with personal link to set their profile and enter the virtual Congress platform.  Your personal link will only be valid until the end of the Congress.  In order to view the Congress lectures and panel discussions, delegates must enter the virtual Congress platform and set their profile before the end of the Congress.